MedTrace Logo

A Dose-response Study of Lidocaine and Etomidate

NCT01916642 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-08-05

No results posted yet for this study

Summary

IV lidocaine administration can reduce the minimal amount of Etomidate and time for induction of anesthesia.

Conditions

  • Etomidate Overdose of Undetermined Intent

Interventions

DRUG

Lidocaine 1mg/kg

The total dosage of Etomidate needed for induction of anesthesia is recorded at last.

DRUG

Lidocaine 1.5mg/kg

same as other

DRUG

Lidocaine 2mg/kg

same as other

DRUG

Lidocaine 2.5mg/kg

same as other

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Liu Jin, MD · West China Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-06-30
Completion
2013-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01916642 on ClinicalTrials.gov